AdAlta CEO Sam Cobb spoke with Tabetha Moreto from Health Radio Online, discussing AdAlta, its drug discovery platform, the i-body, as well as lead candidate, AD-114, for the treatment of idiopathic pulmonary fibrosis.
Listen to the interview below:
AdAlta CEO Sam Cobb spoke with Tabetha Moreto from Health Radio Online, discussing AdAlta, its drug discovery platform, the i-body, as well as lead candidate, AD-114, for the treatment of idiopathic pulmonary fibrosis.
Listen to the interview below: